Khiron Life Sciences Corp. (KHRN.V) Research

Khiron Life Sciences Corp. is an integrated enterprise focusing on medical and cannabis solutions across Latin America and Europe. Its operations are structured into Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company's primary activities include the cultivation, production, distribution, and international export of medical cannabis, encompassing both tetrahydrocannabinol (THC) and cannabidiol (CBD). Complementing this, Khiron manages a network of health centers and satellite clinics, operating under the ILANS and Zerenia brands, with specific Zerenia clinics established in Medellin and Peru. Furthermore, it develops CBD-infused cosmeceutical products marketed under the Kuida brand. Khiron Life Sciences Corp. was founded in 2012 and maintains its headquarters in Vancouver, Canada.

Market snapshot

Symbol
KHRN.V
Price
$0.04
Day change
0.00%
Market cap
$9.3M
P/E ratio
-0.20x
52-week range
0.035-0.165
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aleafia Health Inc. (AH.TO)
  • Australis Capital Inc. (AUSA.CN)
  • Heritage Cannabis Holdings Corp. (CANN.CN)
  • CanaFarma Hemp Products Corp. (CNFA.CN)
  • PharmaCielo Ltd. (PCLO.V)
  • Sunniva Inc. (SNN.CN)
  • Sproutly Canada Inc. (SPR.CN)
  • StateHouse Holdings Inc. (STHZ.CN)

Open Khiron Life Sciences Corp. (KHRN.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.